Kügler Fabian, Ermert Johannes, Kaufholz Peter, Coenen Heinz H
Institute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich, 52425 Jülich, Germany.
Molecules. 2014 Dec 31;20(1):470-86. doi: 10.3390/molecules20010470.
Substituted phenylpiperazines are often neuropharmacologically active compounds and in many cases are essential pharmacophores of neuroligands for different receptors such as D2-like dopaminergic, serotoninergic and other receptors. Nucleophilic, no-carrier-added (n.c.a.) 18F-labelling of these ligands in an aromatic position is desirable for studying receptors with in vivo molecular imaging. 1-(4-[18F]Fluorophenyl)piperazine was synthesized in two reaction steps starting by 18F-labelling of a iodobenzene-iodonium precursor, followed by Pd-catalyzed N-arylation of the intermediate 4-[18F]fluoro-iodobenzene. Different palladium catalysts and solvents were tested with particular attention to the polar solvents dimethylformamide (DMF) and dimethylsulfoxide (DMSO). Weak inorganic bases like potassium phosphate or cesium carbonate seem to be essential for the arylation step and lead to conversation rates above 70% in DMF which is comparable to those in typically used toluene. In DMSO even quantitative conversation was observed. Overall radiochemical yields of up to 40% and 60% in DMF and DMSO, respectively, were reached depending on the labelling yield of the first step. The fluorophenylpiperazine obtained was coupled in a third reaction step with 2-formyl-1H-indole-5-carbonitrile to yield the highly selective dopamine D4 ligand [18F]FAUC 316.
取代苯基哌嗪通常是具有神经药理活性的化合物,在许多情况下是针对不同受体(如D2样多巴胺能受体、5-羟色胺能受体和其他受体)的神经配体的重要药效基团。为了通过体内分子成像研究受体,对这些配体在芳香位置进行亲核、无载体添加(n.c.a.)的18F标记是很有必要的。1-(4-[18F]氟苯基)哌嗪通过两个反应步骤合成,首先是对碘苯 - 碘鎓前体进行18F标记,然后是中间体4-[18F]氟碘苯的钯催化N - 芳基化反应。测试了不同的钯催化剂和溶剂,特别关注极性溶剂二甲基甲酰胺(DMF)和二甲基亚砜(DMSO)。像磷酸钾或碳酸铯这样的弱无机碱似乎对芳基化步骤至关重要,在DMF中能使转化率高于70%,这与通常使用的甲苯中的转化率相当。在DMSO中甚至观察到了定量转化。根据第一步的标记产率,在DMF和DMSO中分别达到了高达40%和60%的总放射化学产率。所得到的氟苯基哌嗪在第三步反应中与2-甲酰基-1H-吲哚-5-腈偶联,生成高选择性多巴胺D4配体[18F]FAUC 316。